Ac Immune Sa (ACIU) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access ACIU Annual Income Statement →
Quarterly income statement trends provide context on Ac Immune Sa's margins, operating leverage, and earnings trajectory.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
Q4 2025
0 0 0 (Dec 31 2024)
Revenues
Revenue From Contracts With Customers3.57
Total Revenue3.57
Costs & Expenses
Gross Profit3.57
Selling, Administration, Marketing16.09
Research and Development Expense56.44
OtherOperating Income Expense0.36
Total operating costs including COS72.89
Operating income / -loss-69.32
Net Interest Expense / -Income0.00
Other loss / -income1.13
Total costs & expenses74.02
Income & Taxes
Income / -loss before income taxes-70.45
Income taxes expenses / -benefit0.00
Income after income taxes-70.45
Income / -loss from continuing operations-70.45
Net income / -loss-70.45
Income / -loss to shareholder-70.45
EBIT-70.45
EBITD-69.05
EBITDA-69.05
Earnings Per Share
Basic EPS (excl. extra items)0.00
Basic Net EPS0.00
Basic shares outstanding (Mill. of Units)100.75
Diluted Net EPS0.00
Diluted average shares (Mill. of Units)100.75
4 historic quarters locked

Sign in to unlock the full Ac Immune Sa income statement history.

About ACIU Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.